Vertex Pharmaceuticals (VRTX) is back in focus after Wolfe Research upgraded the stock to Outperform, citing increased ...

A new way to escalate privileges inside Google’s Vertex AI highlights a broader problem: Enterprises have a level of trust in ...

You can find the Vertex Watch Company tucked among the narrow cobbled streets, quaint boutiques and flower-decked pubs of London's Shepherd Market. It fits right in. Inside its Georgian townhouse HQ, ...

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has approved medicines that treat the ...

Vertex Pharmaceuticals stock was heading for a double-digit gain this year until recent weeks. The company is approaching an important turning point -- one that could set the tone for revenue growth.

Vertex Pharmaceuticals (VRTX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near ...

Vertex Pharmaceuticals, a leader in Cystic Fibrosis treatment, reported strong financials in Q2 but faces limited growth in CF due to high market penetration. Despite a GAAP net loss in Q2, Vertex ...

Vertex and partner CRISPR Therapeutics just won FDA approval for blood disorders treatment exa-cel -- to be commercialized as Casgevy. Vertex is known for its cystic fibrosis drugs, which bring in ...